CTD-2207O23.3 | Rho guanine nucleotide exchange factor 18 {ECO:0000313|Ensembl:ENSP00000471597} | Predicted intracellular proteins
| | | | | Tissue enhanced |
CTLA4 | Cytotoxic T-lymphocyte-associated protein 4 | CD markers Disease related genes FDA approved drug targets Predicted intracellular proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
CXCR3 | Chemokine (C-X-C motif) receptor 3 | CD markers G-protein coupled receptors Predicted membrane proteins
| | | | | Tissue enhanced |
DCANP1 | Dendritic cell-associated nuclear protein | Predicted intracellular proteins
| | | | | Tissue enhanced |
DENND1C | DENN/MADD domain containing 1C | Predicted intracellular proteins
| | | | | Tissue enhanced |
DENND2D | DENN/MADD domain containing 2D | Predicted intracellular proteins
| | | | | Tissue enhanced |
EAF2 | ELL associated factor 2 | Predicted intracellular proteins
| | | | | Tissue enhanced |
EOMES | Eomesodermin | Disease related genes Predicted intracellular proteins Transcription factors
| | | | | Tissue enhanced |
FAIM3 | Fas apoptotic inhibitory molecule 3 | Predicted intracellular proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
FAM111B | Family with sequence similarity 111, member B | Disease related genes Predicted intracellular proteins
| | | | | Tissue enhanced |
FAM159A | Family with sequence similarity 159, member A | Predicted membrane proteins
| | | | | Tissue enhanced |
FAM72B | Family with sequence similarity 72, member B | Predicted intracellular proteins
| | | | | Tissue enhanced |
FAM72C | Family with sequence similarity 72, member C | Predicted intracellular proteins
| | | | | Tissue enhanced |
FAM72D | Family with sequence similarity 72, member D | Predicted intracellular proteins
| | | | | Tissue enhanced |
FASLG | Fas ligand (TNF superfamily, member 6) | Cancer-related genes CD markers Disease related genes Plasma proteins Predicted membrane proteins RAS pathway related proteins
| | | | | Tissue enhanced |
FCAMR | Fc receptor, IgA, IgM, high affinity | CD markers Predicted intracellular proteins Predicted membrane proteins
| | | | | Tissue enhanced |
FCRL1 | Fc receptor-like 1 | CD markers Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
FCRL5 | Fc receptor-like 5 | CD markers Disease related genes Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
FLT3 | Fms-related tyrosine kinase 3 | Cancer-related genes CD markers Disease related genes Enzymes FDA approved drug targets Predicted membrane proteins
| | | | | Tissue enhanced |
FYB | FYN binding protein | Predicted intracellular proteins
| | | | | Tissue enhanced |
GBP5 | Guanylate binding protein 5 | Predicted intracellular proteins
| | | | | Tissue enhanced |
GCSAM | Germinal center-associated, signaling and motility | Predicted intracellular proteins
| | | | | Tissue enhanced |
GP1BA | Glycoprotein Ib (platelet), alpha polypeptide | CD markers Disease related genes Plasma proteins Predicted membrane proteins
| | | | | Tissue enhanced |
GP5 | Glycoprotein V (platelet) | CD markers Plasma proteins Predicted membrane proteins
| | | | | Tissue enhanced |
GPR114 | G protein-coupled receptor 114 | G-protein coupled receptors Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
GPR174 | G protein-coupled receptor 174 | G-protein coupled receptors Predicted membrane proteins
| | | | | Tissue enhanced |
GPR18 | G protein-coupled receptor 18 | G-protein coupled receptors Predicted membrane proteins
| | | | | Tissue enhanced |
GPR31 | G protein-coupled receptor 31 | G-protein coupled receptors Predicted membrane proteins
| | | | | Tissue enhanced |
GRAP | GRB2-related adaptor protein | Plasma proteins Predicted intracellular proteins
| | | | | Tissue enhanced |
GRAP2 | GRB2-related adaptor protein 2 | Plasma proteins Predicted intracellular proteins
| | | | | Tissue enhanced |
GRAPL | GRB2-related adaptor protein-like | Predicted intracellular proteins
| | | | | Tissue enhanced |
GZMA | Granzyme A (granzyme 1, cytotoxic T-lymphocyte-associated serine esterase 3) | Enzymes Predicted secreted proteins
| | | | | Tissue enhanced |
GZMK | Granzyme K (granzyme 3; tryptase II) | Enzymes Predicted secreted proteins
| | | | | Tissue enhanced |
GZMM | Granzyme M (lymphocyte met-ase 1) | Enzymes Plasma proteins Predicted intracellular proteins Predicted secreted proteins
| | | | | Tissue enhanced |
HAPLN3 | Hyaluronan and proteoglycan link protein 3 | Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
HIST1H3J | Histone cluster 1, H3j | Predicted intracellular proteins
| | | | | Tissue enhanced |
HLA-DQA2 | Major histocompatibility complex, class II, DQ alpha 2 | Predicted membrane proteins
| | | | | Tissue enhanced |
HLA-DQB1 | Major histocompatibility complex, class II, DQ beta 1 | Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
ICOS | Inducible T-cell co-stimulator | CD markers Disease related genes Predicted membrane proteins
| | | | | Tissue enhanced |
IDO1 | Indoleamine 2,3-dioxygenase 1 | Cancer-related genes Enzymes Predicted intracellular proteins
| | | | | Tissue enhanced |
IFNG | Interferon, gamma | Cancer-related genes Disease related genes FDA approved drug targets Plasma proteins Predicted secreted proteins
| | | | | Tissue enhanced |
IKZF1 | IKAROS family zinc finger 1 (Ikaros) | Cancer-related genes Disease related genes Predicted intracellular proteins Predicted membrane proteins Transcription factors
| | | | | Tissue enhanced |
IKZF3 | IKAROS family zinc finger 3 (Aiolos) | Predicted intracellular proteins Transcription factors
| | | | | Tissue enhanced |
IL12RB1 | Interleukin 12 receptor, beta 1 | CD markers Disease related genes Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
IL21R | Interleukin 21 receptor | Cancer-related genes CD markers Disease related genes Predicted membrane proteins
| | | | | Tissue enhanced |
IL2RA | Interleukin 2 receptor, alpha | Cancer-related genes CD markers Disease related genes FDA approved drug targets Plasma proteins Predicted intracellular proteins Predicted membrane proteins
| | | | | Tissue enhanced |
IL2RG | Interleukin 2 receptor, gamma | Cancer-related genes CD markers Disease related genes FDA approved drug targets Predicted intracellular proteins Predicted membrane proteins
| | | | | Tissue enhanced |
IL7R | Interleukin 7 receptor | Cancer-related genes CD markers Disease related genes Predicted intracellular proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
ISG20 | Interferon stimulated exonuclease gene 20kDa | Enzymes Predicted intracellular proteins
| | | | | Tissue enhanced |
ITGAL | Integrin, alpha L (antigen CD11A (p180), lymphocyte function-associated antigen 1; alpha polypeptide) | CD markers FDA approved drug targets Predicted intracellular proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |